AI Assistant
Blog
Pricing
Log In
Sign Up
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.